Johnson & Johnson Medtech announced that it has acquired Laminar Inc., a fund III portfolio company of health care and life sciences investment firm Sante Ventures, for $400 million in upfront payments, with additional clinical and regulatory milestone payments expected in 2024 and beyond. California-based Laminar was represented by a Latham & Watkins corporate deal team led by Boston-based partners Hans Brigham and Evan Smith. Counsel information for Johnson & Johnson was not immediately available.
Biotech & Pharmaceuticals
December 05, 2023, 10:04 AM